A detailed history of Lvw Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lvw Advisors, LLC holds 11,623 shares of BMY stock, worth $618,227. This represents 0.08% of its overall portfolio holdings.

Number of Shares
11,623
Previous 11,816 1.63%
Holding current value
$618,227
Previous $490,000 22.65%
% of portfolio
0.08%
Previous 0.07%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$39.66 - $51.75 $7,654 - $9,987
-193 Reduced 1.63%
11,623 $601,000
Q2 2024

Jul 15, 2024

SELL
$40.25 - $52.99 $427,213 - $562,435
-10,614 Reduced 47.32%
11,816 $490,000
Q1 2024

Apr 17, 2024

BUY
$47.98 - $54.4 $4,174 - $4,732
87 Added 0.39%
22,430 $1.22 Million
Q4 2023

Jan 12, 2024

SELL
$48.48 - $57.85 $774,371 - $924,038
-15,973 Reduced 41.69%
22,343 $1.15 Million
Q3 2023

Oct 10, 2023

SELL
$57.89 - $64.73 $1.72 Million - $1.93 Million
-29,777 Reduced 43.73%
38,316 $2.22 Million
Q2 2023

Jul 14, 2023

SELL
$63.71 - $70.74 $223,303 - $247,943
-3,505 Reduced 4.9%
68,093 $4.35 Million
Q1 2023

May 02, 2023

BUY
$65.71 - $74.53 $159,675 - $181,107
2,430 Added 3.51%
71,598 $4.96 Million
Q4 2022

Jan 18, 2023

BUY
$68.48 - $81.09 $44,922 - $53,195
656 Added 0.96%
69,168 $0
Q3 2022

Oct 13, 2022

BUY
$0.13 - $76.84 $202 - $119,486
1,555 Added 2.32%
68,512 $4.87 Million
Q2 2022

Jul 22, 2022

SELL
$72.62 - $79.98 $19,099 - $21,034
-263 Reduced 0.39%
66,957 $5.16 Million
Q1 2022

May 02, 2022

BUY
$61.48 - $73.72 $463,866 - $556,217
7,545 Added 12.64%
67,220 $4.91 Million
Q4 2021

Jan 26, 2022

BUY
$53.63 - $62.52 $241,388 - $281,402
4,501 Added 8.16%
59,675 $3.72 Million
Q3 2021

Nov 02, 2021

BUY
$59.17 - $69.31 $191,829 - $224,703
3,242 Added 6.24%
55,174 $3.27 Million
Q2 2021

Jul 15, 2021

BUY
$61.91 - $67.42 $1 Million - $1.09 Million
16,161 Added 45.18%
51,932 $3.47 Million
Q1 2021

Apr 19, 2021

BUY
$59.34 - $66.74 $1.77 Million - $1.99 Million
29,834 Added 502.51%
35,771 $2.26 Million
Q4 2020

Feb 04, 2021

BUY
$57.74 - $65.43 $133,379 - $151,143
2,310 Added 63.69%
5,937 $368,000
Q3 2020

Oct 29, 2020

BUY
$57.43 - $63.64 $208,298 - $230,822
3,627 New
3,627 $219,000
Q1 2020

Apr 23, 2020

SELL
$46.4 - $67.43 $171,772 - $249,625
-3,702 Closed
0 $0
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $182,175 - $237,631
3,702 New
3,702 $238,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lvw Advisors, LLC Portfolio

Follow Lvw Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvw Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lvw Advisors, LLC with notifications on news.